AA
DMAQR

Ancora Advisors’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Ancora Advisors’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,155
Closed -$722 – 1844
2023
Q2 		$722 Sell
5,155
-45
-0.9% -$7 ﹤0.01% 1600
2023
Q1 		$755 Hold
5,200
– – ﹤0.01% 1662
2022
Q4 		$0 Hold
5,200
– – ﹤0.01% 2115
2022
Q3 		$0 Hold
5,200
– – ﹤0.01% 2287
2022
Q2 		$1K Buy
+5,200
New +$847 ﹤0.01% 2148
2022
Q1 		– Sell
-5,000
Closed -$2K – 2609
2021
Q4 		$2K Buy
+5,000
New +$1.58K ﹤0.01% 2224

Other funds holding DMAQR

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Ancora Advisors's DMAQR Position: Q3 2023 in Review

Ancora Advisors sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q3 2023, closing a stake of 5,155 shares — an estimated $722 sold.

Ancora Advisors first reported a position in DMAQR in Q4 2021 and held it in 6 quarters. The position peaked at $2K in Q4 2021. 26 funds tracked by Wall St. Rank hold DMAQR as of Q3 2023.

  • Ancora Advisors reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q3 2023 after selling out during the quarter.
  • Ancora Advisors sold 5,155 Deep Medicine Acquisition Corp. Rights shares in Q3 2023, an estimated $722.
  • Ancora Advisors first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 6 quarters.
  • Ancora Advisors's Deep Medicine Acquisition Corp. Rights position peaked at $2K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q3 2023.

Based on Ancora Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.